Xencor (XNCR) Earnings Date & Reports

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XNCR is expected to report earnings to -62 cents per share on May 08

Q1'25

Est.

$-0.62

Q4'24

Beat

by $0.19

Q3'24

Beat

by $0.27

Q2'24

Missed

by $0.25

Q1'24

Missed

by $0.30

The last earnings report on February 28 showed earnings per share of -62 cents, beating the estimate of -81 cents. With 826.15K shares outstanding, the current market capitalization sits at 627.11M.

View a ticker or compare two or three

Compare

XNCR